SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,515 | +21.0% | 3,733 | +14.3% | 0.01% | +40.0% |
| Q2 2023 | $373,907 | +71.5% | 3,265 | +155.7% | 0.01% | +25.0% |
| Q4 2020 | $218,000 | +3.8% | 1,277 | -14.2% | 0.00% | 0.0% |
| Q3 2020 | $210,000 | +556.2% | 1,489 | +365.3% | 0.00% | +300.0% |
| Q1 2020 | $32,000 | -23.8% | 320 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $42,000 | +68.0% | 327 | -0.6% | 0.00% | 0.0% |
| Q3 2019 | $25,000 | -50.0% | 329 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $50,000 | +19.0% | 328 | -7.9% | 0.00% | 0.0% |
| Q1 2019 | $42,000 | -17.6% | 356 | -23.6% | 0.00% | 0.0% |
| Q4 2018 | $51,000 | +1175.0% | 466 | +370.7% | 0.00% | – |
| Q3 2017 | $4,000 | – | 99 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |